Cargando…
Unlocking the potential of microfluidics in mass spectrometry-based immunopeptidomics for tumor antigen discovery
The identification of tumor-specific antigens (TSAs) is critical for developing effective cancer immunotherapies. Mass spectrometry (MS)-based immunopeptidomics has emerged as a powerful tool for identifying TSAs as physical molecules. However, current immunopeptidomics platforms face challenges in...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326451/ https://www.ncbi.nlm.nih.gov/pubmed/37426761 http://dx.doi.org/10.1016/j.crmeth.2023.100511 |